Benjamin Sullivan,Tannin A. Schmidt,David A. Sullivan
申请号：
US12605024
公开号：
US08506944B2
申请日:
2009.10.23
申请国别(地区):
US
年份:
2013
代理人:
摘要：
An ophthalmic composition, and methods of use thereof, including for treating ocular boundary deficiency, symptoms associated therewith, or undesired condition that is associated with or causes ocular boundary deficiency at the ocular surface or for the treatment or care of ophthalmic devices. The ophthalmic composition comprises a human PRG4 protein, a lubricant fragment, homolog, or isoform thereof, suspended in an ophthalmically acceptable balanced salt solution. The ophthalmic composition may also comprise one or more ophthalmically acceptable agents.
